Pharmaceutical composition for treating tinea manus and pedis

A composition and technology for tinea pedis, applied in the directions of drug combination, drug delivery, and pharmaceutical formulation, can solve the problems of many adverse reactions, easy recurrence, and narrow application area, and achieve painless treatment, low treatment cost, and good safety. Effect

Inactive Publication Date: 2018-10-12
ANHUI UNIVERSITY
View PDF3 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Benefits of technology

The inventive medicine described by this patented product can be used externally without causing any harm or side-effects that may occur during its administration process. Its technical benefits include ease of handling, safeness, effective treatments with minimal discomfort from injection, rapid results, accuracy, and no recurrence over time.

Problems solved by technology

This patented technical problem addressed in this patents relates to finding better ways to fight against these two types of germ-borne illness: those caused by certain bacteria called Triticium sppage (TSC) which affect humans during their lifetime; and those due to various forms of environmental exposures like pollution from industrial sources including coal burning fires and road dust storms. Current therapies involve either systematic administration of different agents or chemotherapy alone, leading to side effects and resistant strains. Therefore, researchers aim towards developing novel methods to improve upon existing antipsorials without causing harmful side effects.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0032] A pharmaceutical composition for the treatment of tinea manus and pedis, comprising the following raw material components in parts by weight:

[0033] Mixed Enzyme 32, Caprylic Acid 5.0, Oregano Extract 5.0, Lemongrass Oil 5.0, Garlic Oil 5.0, Salicylic Acid 5.0, Dimethyl Sulfoxide 20;

[0034] Among them, the mixed enzyme is composed of 350 enzyme units of protease, 500 enzyme units of amylase, and 100 enzyme units of lipase;

[0035] Oregano extract is prepared through the following steps:

[0036] Remove impurities from the oregano medicinal material, wash, dry, and crush, add 5 times the volume concentration of 0.6% acetic acid aqueous solution, soak for 2 hours, filter, discard the filtrate, and add 10 times the volume of 75% ethanol to it after the filter residue is dried , soaked for 2 hours, then refluxed for 1 hour, filtered the medicinal liquid, and the filtrate was used for later use. Under the same conditions, the medicinal dregs were repeatedly extracted o...

Embodiment 2

[0038] A pharmaceutical composition for the treatment of tinea manus and pedis, comprising the following raw material components in parts by weight:

[0039] Mixed enzyme 30, caprylic acid 4.5, oregano extract 4.5, lemongrass oil 4.6, garlic oil 4.6, salicylic acid 4.5, dimethyl sulfoxide 18;

[0040] Among them, the mixed enzyme is composed of 350 enzyme units of protease, 500 enzyme units of amylase, and 100 enzyme units of lipase;

[0041] The preparation method of oregano extract is the same as in Example 1.

Embodiment 3

[0043] A pharmaceutical composition for the treatment of tinea manus and pedis, comprising the following raw material components in parts by weight:

[0044] Mixed enzyme 35, caprylic acid 5.5, oregano extract 5.5, lemongrass oil 5.2, garlic oil 5.2, salicylic acid 5.5, dimethyl sulfoxide 21;

[0045] Among them, the mixed enzyme is composed of 350 enzyme units of protease, 500 enzyme units of amylase, and 100 enzyme units of lipase;

[0046] The preparation method of oregano extract is the same as in Example 1.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention relates to the field of medicines for external use, and in particular to a pharmaceutical composition for treating tinea manus and pedis. The pharmaceutical composition consists of mixedenzyme, caprylic acid, an oregano extract, lemongrass oil, garlic oil, salicylic acid and dimethyl sulfoxide in specific parts by weight, wherein the mixed enzyme is composed of protease, amylase andlipase. Based upon tests, the pharmaceutical composition provided by the invention has an ideal therapeutic effect on the tinea manus and pedis; and the composition provided by the invention, as a pharmaceutical preparation for external use, has the characteristics of being convenient to use, good in safety, free from pain in treatment, rapid to take effects, definite in curative effect, less inrecurrence after curing, broad in application scope, low in treatment cost and the like.

Description

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Owner ANHUI UNIVERSITY
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap